Jefferies Initiates Coverage On Beta Bionics with Buy Rating, Announces Price Target of $30
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Jefferies analyst Michael Toomey initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Buy rating and announces Price Target of $30.
Jefferies analyst Michael Toomey initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Buy rating and announces Price Target of $30.